Skip to main content
Caplight Logo









Diamens

Diamens

Private
LinzHealthcare & Life Scienceshttps://www.futurefemhealth.com/

Last Round

Pre Seed

Mar 17, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Diamens is a healthtech company developing a non-invasive, at-home molecular diagnostic test for endometriosis using menstrual blood.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2C

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

endometriosis testat-home diagnosticFemTechmenstrual blood testnon-invasive screeningpolymerase chain reactionPCRbiotechnologywomen's healthprecision medicinebiomarker discoveryperiod healthdirect-to-consumer diagnosticsDTC healthmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Diamens Comparables

Compare Diamens with similar companies based on industry and business-model similarity.

Diamens comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
theblood
87%
DotLab
77%
Hera Biotech
77%

Diamens Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 17, 2026

Diamens Investors

Notable investors and investment history

Diamens investors
InvestorRounds
EQventurePre Seed
VP Venture PartnersPre Seed
FS Life Science InvestmentPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 17, 2026

    EQventure led the round with FS Life Science Investment and VP Venture Partners.

  • Jan 25, 2025

    Monthly visitors increased 58% MoM, from 1.9K to 3K.

Diamens Filings

Explore SEC and related filing metadata, where available.

Diamens filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Diamens's valuation, stock price, and market status.

Is Diamens a public or private company?

Diamens is a private company.

What is the current stock price of Diamens?

Diamens is a private company with no public stock price. No recent secondary market data is available.

How much is Diamens worth (valuation)?

Valuation information for Diamens is not publicly available.

Can I buy Diamens stock?

Diamens shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Diamens's last funding round?

Diamens's most recent funding round was Pre Seed on March 17, 2026.

Who are the main investors in Diamens?

Key investors in Diamens include EQventure.

Will Diamens IPO soon?

No public IPO plans have been announced for Diamens.

How can I track Diamens secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Diamens's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLinz
Employee Range2
Year Founded2024
Last FundingMar 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?